Company / Net Income
PULSE BIOSCIENCES, INC. Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$72.8M
FY2025
5-year range
-$72.8M / -$53.6M
FY2021-FY2025
Trend
-35.8%
vs FY2024
Sector context
#123 of 164
Health Care
What the data says
PULSE BIOSCIENCES, INC.'s net income of -$73M is lower than 75% of companies in the Health Care sector (FY2025). Declined from -$59M to -$73M over the past 2 years.
Based on SEC 10-K filings.
-$73M in FY2025.
Declined from -$59M to -$73M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 25% in Health CareTop 75% of 164This company -$72.8M Sector average $467.5M
▼
-115.6% below sector average
Key checks
Key Insights
- In FY2025, net income decreased 35.8% year-over-year.
- Ranks #123 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$72.8M | -35.8% |
| FY2024 | -$53.6M | +8.4% |
| FY2023 | -$58.5M | +0.0% |
| FY2022 | -$58.5M | +8.1% |
| FY2021 | -$63.7M | -27.7% |
| FY2020 | -$49.9M | -6.1% |
| FY2019 | -$47.0M | -25.1% |
| FY2018 | -$37.5M | -46.8% |
| FY2017 | -$25.6M | -168.6% |
| FY2016 | -$9.5M | -238.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026